PBI is always actively seeking opportunities to collaborate with research sponsors and collaborative/academic institutions to promote research into the causes, prevention, and treatments for blood disorders, including blood cancers. Part of PBI’s mission is to facilitate access to new and promising therapies for patients in need, not only within Perth, but also regionally within Western Australia. PBI has grown to become one of the largest privately-funded, haematology-focussed clinical research institutes within Western Australia.
If you are interested in collaborating with PBI's Clinical Trials Division, please contact us.
Currently, the Asia Pacific Microangiopathic Thrombocytompenia Network (APMAT) are collaborating with PBI's Clinical Trials Division on the APMAT1 (Microangiopathic Thrombocytopenia; Thrombotic Thrombocytopenic Pupura; Atypical Hemolytic Uremic Syndrome) project.